Recent Finacing
Recent Raise
Ensoma develops in vivo hematopoietic stem-cell engineering therapies intended to deliver one-time, potentially curative genetic medicines for diseases such as X-CGD, sickle cell disease, and cancer.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Ensoma.
